European Journal of Nuclear Medicine and Molecular Imaging - Featured content on TSPO Imaging

Please also check the respective themed section on issue level (see Issue 1/2022) at https://link.springer.com/journal/259/volumes-and-issues. Here you will find all topical special issues or themed sections published so far.

Wimberley, C., Buvat, I. & Boutin, H.

Imaging translocator protein expression with positron emission tomography

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05601-y

Van Camp, N., Lavisse, S., Roost, P. et al.

TSPO imaging in animal models of brain diseases

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05379-z

Lee, S.H., Denora, N., Laquintana, V. et al.

Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05617-4

Ramakrishnan, N.K., Hird, M., Thompson, S. et al.

Preclinical evaluation of (S)-[18F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05495-w

MacAskill, M.G., Wimberley, C., Morgan, T.E.F. et al.

Modelling [18F]LW223 PET data using simplified imaging protocols for quantification of TSPO expression in the rat heart and brain

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05482-1

Nutma, E., Ceyzériat, K., Amor, S. et al.

Cellular sources of TSPO expression in healthy and diseased brain

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-020-05166-2

De Picker, L.J., Haarman, B.C.M.

Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05308-0

Zinnhardt, B., Roncaroli, F., Foray, C. et al.

Imaging of the glioma microenvironment by TSPO PET

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05276-5

Leroy, C., Saba, W.

Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05408-x

Chauveau, F., Becker, G. & Boutin, H.

Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05425-w

Bouilleret, V., Dedeurwaerdere, S.

What value can TSPO PET bring for epilepsy treatment?

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05449-2

Dirks, M., Buchert, R., Wirries, AK. et al.

Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05398-w

Wimberley, C., Lavisse, S., Hillmer, A. et al.

Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05248-9

Schubert, J., Tonietto, M., Turkheimer, F. et al.

Supervised clustering for TSPO PET imaging

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05309-z